Weight loss after Wegovy: the realistic picture

The biggest myth: stopping Wegovy locks in your results permanently

A lot of people assume that once the weight is gone, it stays gone, that Wegovy has somehow reset the body's set point. It is an understandable hope, and it is worth letting it go gently, because the evidence tells a more complicated story.

The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight reduction of around 15% over 68 weeks on semaglutide 2.4mg. A follow-up study (STEP 4) then withdrew the medicine at week 20, replacing it with placebo for a further 48 weeks. Participants regained, on average, roughly two-thirds of the weight they had lost by the end of that follow-up period. Average body weight returned close to baseline.

That is not a reason to feel defeated. It reflects how obesity works as a condition, appetite-regulating hormones, metabolic rate and the body's drive to restore lost fat all push back when the pharmacological support is removed. The NHS describes this biological mechanism on its obesity treatment guidance page. The weight returning is the illness reasserting itself, not evidence that the treatment failed or that you did something wrong.

Understanding this is the starting point for planning what comes after a course of semaglutide, whether that means continuing treatment, stepping down gradually, or building on the habits formed during the period when appetite was lower.

What actually shapes how much weight stays off

Several things influence long-term outcome after Wegovy, and most of them were put in place during treatment rather than after it.

Protein intake matters more than many realise. When body weight falls rapidly, a portion of what is lost is lean muscle mass. Prioritising protein during treatment helps preserve muscle, which in turn supports a healthier resting metabolic rate afterwards. Resistance exercise during treatment has a similar effect, people who built some strength during the months on semaglutide tend to maintain more of the metabolic benefit.

The dose reached also plays a role. Someone who titrated to 2.4mg and held that dose for most of their treatment period typically sees different results from someone who spent most of their time at a lower dose because of tolerability. If you are curious about how Wegovy weight loss works and what results to expect, that page explains how dose and duration interact in more detail.

Sleep, stress and a stable eating pattern all contribute too. None of these are things a medicine can fix, but the months on treatment can provide a window to address them without the constant noise of intense hunger. If you want a sense of the kind of progress that is realistic early on, our page on what wegovy weight loss after 1 month typically looks like gives useful context for setting expectations at each stage. That window is the real opportunity, and it is finite.

Finally, the circumstances under which treatment ends matter. Stopping because you have reached your goal and feel confident in new habits is a different situation from stopping because supply ran out or cost became a barrier. The cost context for Wegovy in the UK is worth understanding if affordability is part of your planning.

The first months after stopping: what is normal

In the weeks after the last dose, appetite typically returns. For many people this is gradual; for others it feels abrupt, particularly if the dose was stopped suddenly rather than tapered. Food feels more rewarding again. Portion sizes that felt natural during treatment may feel less satisfying.

Some weight gain in the first one to three months after stopping is very common. How weight changes after finishing Wegovy covers this period in detail, including what is typical and what might signal something else worth checking. The key distinction is between the body's natural recalibration and a pattern that is accelerating beyond it.

A few practical things help during this window. Keeping regular meals rather than waiting until hungry tends to prevent the sharpest appetite swings. Continuing any exercise routine built during treatment is one of the better investments of effort at this stage. And staying connected to a clinician (rather than waiting until significant regain has happened) means any decision about restarting can be made from a position of information rather than urgency.

If your treatment was through nume, our prescribers are available seven days a week for aftercare questions. You can reach the team via our contact page at any point during or after treatment.

When restarting or continuing treatment is the right conversation

NICE's appraisal of semaglutide (TA875) specifies that NHS use is limited to a maximum of two years within a specialist weight management service, which means the question of what comes after is built into the NHS pathway. In private practice, the picture is different: there is no arbitrary ceiling on duration, but every repeat prescription still requires a clinical review. Whether continuing treatment makes sense is a question of individual benefit, tolerability, and health goals, not a default answer either way.

Restarting after a break is possible. The titration schedule would typically begin again from the lowest dose to allow the body to readjust, but the clinical decision rests with the prescriber. Questions about stopping, restarting, and what the transition looks like are among the ones our team hears most often, you can read more about stopping Wegovy after weight loss if that is where you are in your thinking.

If you have not yet started treatment and are weighing your options, an overview of weight-loss treatments available in the UK is a useful place to begin. When you are ready to speak to a prescriber, check your eligibility for a free consultation and our clinical team will review your case the same day.